Human cells evolving in the laboratory undergo a series of predictable, sequential genetic changes that lead to pre-cancer. Blocking these changes may allow intervention before cancer occurs.

An anticipated growth in veterans seeking cancer care catalyzes talks to develop state-of-the-art collaboration between VA and Stanford Medicine.

Cancer disproportionately impacts persistently impoverished communities. A federal grant unites Stanford Medicine, UC Davis and UCSF to study income supplementation and cancer risk factors.

The goal of the collaboration is to rapidly improve care for patients with tumors that form from hormone-releasing cells.

A new study finds surprisingly low genetic testing rates for cancer patients who may benefit, especially among Asian, Black and Hispanic patients.

The solution to the overdiagnosis and overtreatment of prostate cancer could lie in every man’s genome. Stanford Medicine researchers take a step toward genetically personalized cancer screening.

An international effort led by a Stanford Medicine researcher finds more than 50 genes linked to glioma — a rare brain cancer. Although most gliomas are sporadic, a minority are inherited.

Most children receiving radiation therapy for cancer can hold still without anesthesia if they watch videos during the treatment, a study of a technique developed at Stanford Medicine found.

Triple-negative breast cancer patients who used antibiotics within three years of diagnosis have an increased risk of death, according to a study. The gut microbiome is a likely link.

In a study led by Stanford Medicine, researchers harnessed the skin’s immune response to bacteria to create an immunotherapy — delivered by swab — that treats aggressive tumors in mice.